Bristol Buys Mirati for $4.8 Billion in Cancer Drug Hunt
Bristol-Myers Squibb Co. agreed to buy cancer drug-maker Mirati Therapeutics Inc. for $4.8 billion on Sunday, a price that disappointed investors after reported interest from rival Sanofi.
Bristol-Myers Squibb Co. agreed to buy cancer drug-maker Mirati Therapeutics Inc. for $4.8 billion on Sunday, a price that disappointed investors after reported interest from rival Sanofi.
Huawei Technologies Co. has appealed Spanish government rules that might prevent the Chinese equipment maker from qualifying for state aid.
Gambia plans to open its first stock exchange to help widen funding options for companies in the West African nation where firms have to rely on borrowings and interest rates of as much as 20%.
Daniel Gewehr, the former head of Banco Santander SA’s Latin America equity strategy, is joining Banco Itau BBA SA.
Claudia Goldin shattered two glass ceilings when she was named the laureate of this year’s Nobel Prize in economics.
One of the original architects of a plan to limit Russia’s oil profits proposed steps to fix the faltering program.
The US Federal Reserve’s top bank watchdog is defending a sweeping government plan that would significantly boost capital requirements for Wall Street’s biggest banks.
Gold Fields Ltd. said Michael Fraser will take over as chief executive officer from January, a permanent replacement for Chris Griffith, who stepped down in December.
Switzerland has increased the number of countries with which it is sharing information on financial assets, as part of the country’s international obligations to combat tax evasion.
Caius Capital led a group of creditors that agreed to bolster Metro Bank Holdings Plc’s balance sheet after a weekend of frantic negotiations.